Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,496 public trials 645 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.633.01004 Boehringer Ingelheim Investigational Site Sun City, Arizona, United States
  • 248.633.01018 Boehringer Ingelheim Investigational Site Tempe, Arizona, United States
  • 248.633.01016 Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • 248.633.01013 Boehringer Ingelheim Investigational Site Oxnard, California, United States
View all 119 locations
View Trial Details
Completed

Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

NCT00613301

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Boehringer Ingelheim Investigational Site 11 Akita, Japan
  • Boehringer Ingelheim Investigational Site 95 Anan, Japan
  • Boehringer Ingelheim Investigational Site 1 Asahikawa, Japan
  • Boehringer Ingelheim Investigational Site 2 Asahikawa, Japan
View all 119 locations
View Trial Details
Completed

Safety of Urate Elevation in Parkinson's Disease

NCT00833690

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Eastern Connecticut Neurology Specialists, LLC Manchester, Connecticut, United States
  • Institute for Neurodegenerative Disorders New Haven, Connecticut, United States
  • Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton, Florida, United States
View all 16 locations
View Trial Details
Completed

An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease

NCT00918177

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Barzilai Medical Center, Department of Neurology, Movement disorders unit, Ashkelon, Israel
  • Department of Neurology, Clalit University Medical Center Beersheba, Israel
  • Rambam Health Care Campus, Haifa, Movement Disorders and Parkinson's Disease Haifa, Israel
  • Edith Wolfson , Dept. of Neurology, Movement Disorders Unit. Holon, Israel
View Trial Details
Completed

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

NCT01176240

Conditions
Asthenia, Autonomic Nervous System Diseases, Basal Ganglia Diseases, +24 more
Locations
  • Neurology Neurodiagnostic Lab Alabaster, Alabama, United States
  • Neurological Physicians of Arizona Gilbert, Arizona, United States
  • Xenoscience Phoenix, Arizona, United States
  • Barrow Neurology Clinic Phoenix, Arizona, United States
View all 60 locations
View Trial Details
Completed

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

NCT00633880

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Dedicated Clinical Research Litchfield Park, Arizona, United States
  • Xenoscience Inc. Phoenix, Arizona, United States
  • Sun Health Research Institute Sun City, Arizona, United States
View all 54 locations
View Trial Details

Related conditions